Company profile: Organovo
1.1 - Company Overview
Company description
- Provider of 3D bioprinted human tissue models that mimic human biology for disease modeling, drug discovery, and therapeutic applications, and of drug programs including FXR314, an orally delivered FXR agonist for ulcerative colitis, Crohnβs disease, NASH, and Primary Biliary Cholangitis, plus an undisclosed target program validated in Crohnβs 3D tissue models with an IND expected by 2025.
Products and services
- 3D Human Tissue Models: Organovo engineers bioprinted 3D tissues that mimic human biology for disease modeling, drug discovery, and therapeutic applications
- FXR314: An orally delivered FXR agonist engineered to treat inflammatory bowel diseasesβulcerative colitis and Crohn'sβand liver diseases including NASH and Primary Biliary Cholangitis
- Novel Drug to Undisclosed Target: A 3D tissue-validated drug program targeting an undisclosed marker in Crohn's disease models, with an Investigational New Drug filing expected by 2025.
Key contacts
π
π
Financial details
π
1.2 - Competitors and similar companies to Organovo
SketchUp
HQ: United States
Website
- Description: Provider of 3D-design and modeling software, developer of the SketchUp software for three-dimensional drawing needs.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: βββββ
- Total funding raised: $βββm
- Backers: ββββββββββ
- Acquisitions: ββ
View full SketchUp company profile β
Realizer
HQ: Germany
Website
- Description: Provider of additive manufacturing systems, specializing in their development and sale.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: βββββ
- Total funding raised: $βββm
- Backers: ββββββββββ
- Acquisitions: ββ
View full Realizer company profile β
3D Matter
HQ: United States
Website
- Description: Provider of engineering solutions for 3D printing users to make functional parts, conducting research on 3D printed materials by measuring mechanical performance, visual quality and processability. Leveraging extensive material data, the company developed OptiMatter, a model that predicts the properties of printed parts.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: βββββ
- Total funding raised: $βββm
- Backers: ββββββββββ
- Acquisitions: ββ
View full 3D Matter company profile β
Desktop Metal
HQ: United States
Website
- Description: Provider of additive manufacturing technologies, materials, software, and applications enabling on-demand, digital mass production for industrial, medical, and consumer products. Offers metal, ceramic, composite, and carbon fiber 3D printing via systems including Production System P-50 (Single Pass Jetting), Shop System, Studio System, X-Series (Triple ACT), InnoventX, and X25Pro for prototyping to continuous production.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: βββββ
- Total funding raised: $βββm
- Backers: ββββββββββ
- Acquisitions: ββ
View full Desktop Metal company profile β
SLM Solutions
HQ: Germany
Website
- Description: Provider of design and promotion of advanced, production-oriented metal additive manufacturing systems.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: βββββ
- Total funding raised: $βββm
- Backers: ββββββββββ
- Acquisitions: ββ
View full SLM Solutions company profile β
π
2.M&A buyers
2.1 Potential strategic acquirers in the sector
π
π
π
π
View all strategic buyers with complete profiles
Start Free Trial β
2.2 - Strategic buyer groups for Organovo
π
Buyer group 1: ββββββββ ββββββββ
ββ companies
Description: ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ
Key Products: ββββββββ, ββββββββ, ββββββββ, ββββββββ
π
View all companies in this group
Request Free Trial Now β
π
Buyer group 2: ββββββββ ββββββββ
ββ companies
Description: ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ
Key Products: ββββββββ, ββββββββ, ββββββββ, ββββββββ
π
View all companies in this group
Request Free Trial Now β
π
Buyer group 3: ββββββββ ββββββββ
ββ companies
Description: ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ
Key Products: ββββββββ, ββββββββ, ββββββββ, ββββββββ
π
View all companies in this group
Request Free Trial Now β
π Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial β
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Organovo
2.2 - Growth funds investing in similar companies to Organovo
π
View all growth equity funds with complete profiles
Start Free Trial β
4 - Top valuation comps for Organovo
4.2 - Public trading comparable groups for Organovo
π Unlock all public trading comparable groups with complete valuation data
Start Free Trial β